Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo.
dc.contributor.author | Tong, J | |
dc.contributor.author | Valverde, O | |
dc.contributor.author | Mahoudeau, C | |
dc.contributor.author | Yun, O | |
dc.contributor.author | Chappuis, F | |
dc.date.accessioned | 2012-03-07T02:44:00Z | |
dc.date.available | 2012-03-07T02:44:00Z | |
dc.date.issued | 2011-05-26 | |
dc.identifier.citation | Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo. 2011, 5:7 Confl Health | en |
dc.identifier.issn | 1752-1505 | |
dc.identifier.pmid | 21615932 | |
dc.identifier.doi | 10.1186/1752-1505-5-7 | |
dc.identifier.uri | http://hdl.handle.net/10144/214529 | |
dc.description.abstract | Human African trypanosomiasis (HAT), or sleeping sickness, is a fatal neglected tropical disease if left untreated. HAT primarily affects people living in rural sub-Saharan Africa, often in regions afflicted by violent conflict. Screening and treatment of HAT is complex and resource-intensive, and especially difficult in insecure, resource-constrained settings. The country with the highest endemicity of HAT is the Democratic Republic of Congo (DRC), which has a number of foci of high disease prevalence. We present here the challenges of carrying out HAT control programmes in general and in a conflict-affected region of DRC. We discuss the difficulties of measuring disease burden, medical care complexities, waning international support, and research and development barriers for HAT. | |
dc.language.iso | en | en |
dc.publisher | BioMed Central | en |
dc.relation.url | http://www.conflictandhealth.com/content/5/1/7 | en |
dc.rights | Archived with thanks to Conflict and Health | en |
dc.subject.mesh | Trypanosomiasis, African | en |
dc.title | Challenges of controlling sleeping sickness in areas of violent conflict: experience in the Democratic Republic of Congo. | en |
dc.type | Article | en |
dc.contributor.department | Médecins Sans Frontières, Rue de Lausanne 78, 1211 Geneva, Switzerland. jacquitong@yahoo.co.uk. | en |
dc.identifier.journal | Conflict and Health | en |
refterms.dateFOA | 2019-03-04T09:42:10Z | |
html.description.abstract | Human African trypanosomiasis (HAT), or sleeping sickness, is a fatal neglected tropical disease if left untreated. HAT primarily affects people living in rural sub-Saharan Africa, often in regions afflicted by violent conflict. Screening and treatment of HAT is complex and resource-intensive, and especially difficult in insecure, resource-constrained settings. The country with the highest endemicity of HAT is the Democratic Republic of Congo (DRC), which has a number of foci of high disease prevalence. We present here the challenges of carrying out HAT control programmes in general and in a conflict-affected region of DRC. We discuss the difficulties of measuring disease burden, medical care complexities, waning international support, and research and development barriers for HAT. |